Lanlan Zang

531 total citations
25 papers, 382 citations indexed

About

Lanlan Zang is a scholar working on Molecular Biology, Organic Chemistry and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Lanlan Zang has authored 25 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Organic Chemistry and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Lanlan Zang's work include Histone Deacetylase Inhibitors Research (5 papers), Epigenetics and DNA Methylation (4 papers) and Carbohydrate Chemistry and Synthesis (4 papers). Lanlan Zang is often cited by papers focused on Histone Deacetylase Inhibitors Research (5 papers), Epigenetics and DNA Methylation (4 papers) and Carbohydrate Chemistry and Synthesis (4 papers). Lanlan Zang collaborates with scholars based in China, United States and Australia. Lanlan Zang's co-authors include Fengyuan Che, Shukkoor Muhammed Kondengaden, Lijuan Wang, Peng George Wang, Kenneth Huang, Liuqing Wen, Xueyuan Heng, Run‐Ling Wang, Houcheng Zhang and Jeffrey Meisner and has published in prestigious journals such as Angewandte Chemie International Edition, Scientific Reports and The Plant Journal.

In The Last Decade

Lanlan Zang

22 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lanlan Zang China	12	252	71	67	49	48	25	382
Fraidoon Kavoosi Iran	15	449 1.8×	46 0.6×	58 0.9×	23 0.5×	119 2.5×	47	582
Masumeh Sanaei Iran	14	401 1.6×	41 0.6×	49 0.7×	17 0.3×	103 2.1×	44	510
Nicoletta Cini Italy	10	170 0.7×	83 1.2×	56 0.8×	37 0.8×	45 0.9×	22	339
Arindom Pal United States	11	286 1.1×	31 0.4×	85 1.3×	8 0.2×	80 1.7×	20	414
Tiantian Wang China	14	273 1.1×	40 0.6×	167 2.5×	50 1.0×	41 0.9×	43	487
Ali Munaim Yousif Italy	16	199 0.8×	66 0.9×	37 0.6×	62 1.3×	39 0.8×	19	391
Anja Bastian United States	12	188 0.7×	114 1.6×	64 1.0×	8 0.2×	97 2.0×	14	357
Lorela Ciraku United States	7	341 1.4×	64 0.9×	141 2.1×	12 0.2×	61 1.3×	9	455
Eun Jin Seo South Korea	12	356 1.4×	20 0.3×	128 1.9×	15 0.3×	121 2.5×	17	498
Ji Won Lee South Korea	10	220 0.9×	23 0.3×	48 0.7×	11 0.2×	34 0.7×	23	311

Countries citing papers authored by Lanlan Zang

Since Specialization

Citations

This map shows the geographic impact of Lanlan Zang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanlan Zang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanlan Zang more than expected).

Fields of papers citing papers by Lanlan Zang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lanlan Zang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanlan Zang. The network helps show where Lanlan Zang may publish in the future.

Co-authorship network of co-authors of Lanlan Zang

This figure shows the co-authorship network connecting the top 25 collaborators of Lanlan Zang. A scholar is included among the top collaborators of Lanlan Zang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lanlan Zang. Lanlan Zang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, G. H., et al.. (2025). Berberine hydrochloride inhibits the proliferation and metastasis of p53 mutant gallbladder Cancer cells by regulating the IL6/STAT3 pathway. Scientific Reports. 15(1). 26808–26808.

Ji, Jiaojiao, Lanlan Zang, Tingting Lu, et al.. (2025). Widely targeted metabolomics analysis reveals differences in volatile metabolites among four Angelica species. Natural Products and Bioprospecting. 15(1). 2–2.

Ji, Jiaojiao, Xiaoxu Han, Lanlan Zang, et al.. (2025). Integrative multi-omics data provide insights into the biosynthesis of furanocoumarins and mechanisms regulating their accumulation in Angelica dahurica. Communications Biology. 8(1). 649–649. 1 indexed citations

Lu, Tingting, Lanlan Zang, Xueqing Chen, et al.. (2024). The haplotype‐resolved genome of diploid Chrysanthemum indicum unveils new acacetin synthases genes and their evolutionary history. The Plant Journal. 119(3). 1336–1352. 6 indexed citations

Chen, Xueqing, Cheng Li, Wenkai Sun, et al.. (2024). Haplotype-phased genome unveils the butylphthalide biosynthesis and homoploid hybrid origin of Ligusticum chuanxiong. Science Advances. 10(6). eadj6547–eadj6547. 14 indexed citations

Hu, Wei‐Wen, et al.. (2024). Advances in epigenetic therapies for B-cell non-hodgkin lymphoma. Annals of Hematology. 103(12). 5085–5101. 1 indexed citations

Zhang, Yu, Xiaoqi Li, Renyu Xue, et al.. (2024). Novel methyltransferase G9a inhibitor induces ferroptosis in multiple myeloma through Nrf2/HO-1 pathway. Annals of Hematology. 103(7). 2405–2417. 8 indexed citations

Zang, Lanlan, et al.. (2024). Concise chemoenzymatic synthesis of N-glycans. Chem. 10(9). 2844–2860. 14 indexed citations

Wang, Liying, et al.. (2021). Potential new targets and drugs related to histone modifications in glioma treatment. Bioorganic Chemistry. 112. 104942–104942. 5 indexed citations

10.

Zhu, Yanxi, Jinling Zhang, Yanchun Quan, et al.. (2021). A self-healing nanocomposite coating with antibacterial, biocompatibility and self-cleaning properties. Materials & Design. 206. 109799–109799. 5 indexed citations

11.

Liu, Jinghua, et al.. (2021). SNHG1 knockdown upregulates miR-376a and downregulates FOXK1/Snail axis to prevent tumor growth and metastasis in HCC. Molecular Therapy — Oncolytics. 21. 264–277. 27 indexed citations

12.

Liu, Changsheng, et al.. (2020). Clinical factors associated with the number of gallbladder polyps. Chinese Medical Journal. 133(22). 2751–2752.

13.

Li, Shanshan, Lanlan Zang, Hai‐Liang Zhu, et al.. (2019). Production of Glycopeptide Derivatives for Exploring Substrate Specificity of Human OGA Toward Sugar Moiety. Frontiers in Chemistry. 6. 646–646. 10 indexed citations

14.

Che, Fengyuan, Xiaoli Xie, Long Wang, et al.. (2018). B7-H6 expression is induced by lipopolysaccharide and facilitates cancer invasion and metastasis in human gliomas. International Immunopharmacology. 59. 318–327. 32 indexed citations

15.

Zang, Lanlan, Shukkoor Muhammed Kondengaden, Fengyuan Che, Lijuan Wang, & Xueyuan Heng. (2018). Potential Epigenetic-Based Therapeutic Targets for Glioma. Frontiers in Molecular Neuroscience. 11. 408–408. 58 indexed citations

16.

Zang, Lanlan, Shukkoor Muhammed Kondengaden, Qing Zhang, et al.. (2017). Structure based design, synthesis and activity studies of small hybrid molecules as HDAC and G9a dual inhibitors. Oncotarget. 8(38). 63187–63207. 30 indexed citations

17.

Kondengaden, Shukkoor Muhammed, Kenneth Huang, Mengyuan Zhu, et al.. (2016). Discovery of novel small molecule inhibitors of lysine methyltransferase G9a and their mechanism in leukemia cell lines. European Journal of Medicinal Chemistry. 122. 382–393. 38 indexed citations

18.

Wen, Liuqing, Kenneth Huang, Mohui Wei, et al.. (2015). Facile Enzymatic Synthesis of Ketoses. Angewandte Chemie International Edition. 54(43). 12654–12658. 60 indexed citations

19.

Wen, Liuqing, Lanlan Zang, Kenneth Huang, et al.. (2015). Efficient enzymatic synthesis of l-rhamnulose and l-fuculose. Bioorganic & Medicinal Chemistry Letters. 26(3). 969–972. 16 indexed citations

20.

Zang, Lanlan, Xuejiao Wang, Xiaobo Li, et al.. (2014). SAHA-based novel HDAC inhibitor design by core hopping method. Journal of Molecular Graphics and Modelling. 54. 10–18. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact